LSPN North America: Method of treatment claims often challenged

08-06-2017

LSPN North America: Method of treatment claims often challenged

fotohunter / iStockphoto.com

Two thirds of biotech claims challenged in inter partes reviews are directed to methods of treatment, said Brendan O’Malley, partner at Fitzpatrick Cella Harper & Scinto, at a recent industry conference.


LSPN, patent, patent challenge, IPR, PGR, biologics, patent dance,

LSIPR